17-75522122-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_207346.3(TSEN54):​c.1041G>C​(p.Lys347Asn) variant causes a missense change. The variant allele was found at a frequency of 0.655 in 1,572,714 control chromosomes in the GnomAD database, including 350,494 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K347Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.53 ( 24673 hom., cov: 33)
Exomes 𝑓: 0.67 ( 325821 hom. )

Consequence

TSEN54
NM_207346.3 missense

Scores

7
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 3.94

Publications

38 publications found
Variant links:
Genes affected
TSEN54 (HGNC:27561): (tRNA splicing endonuclease subunit 54) This gene encodes a subunit of the tRNA splicing endonuclease complex, which catalyzes the removal of introns from precursor tRNAs. The complex is also implicated in pre-mRNA 3-prime end processing. Mutations in this gene result in pontocerebellar hypoplasia type 2.[provided by RefSeq, Oct 2009]
TSEN54 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2A
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • pontocerebellar hypoplasia type 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
  • pontocerebellar hypoplasia type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.242469E-6).
BP6
Variant 17-75522122-G-C is Benign according to our data. Variant chr17-75522122-G-C is described in ClinVar as Benign. ClinVar VariationId is 160123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.691 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSEN54NM_207346.3 linkc.1041G>C p.Lys347Asn missense_variant Exon 8 of 11 ENST00000333213.11 NP_997229.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSEN54ENST00000333213.11 linkc.1041G>C p.Lys347Asn missense_variant Exon 8 of 11 1 NM_207346.3 ENSP00000327487.6

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80268
AN:
152058
Hom.:
24678
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.827
Gnomad AMR
AF:
0.462
Gnomad ASJ
AF:
0.599
Gnomad EAS
AF:
0.461
Gnomad SAS
AF:
0.647
Gnomad FIN
AF:
0.707
Gnomad MID
AF:
0.595
Gnomad NFE
AF:
0.696
Gnomad OTH
AF:
0.543
GnomAD2 exomes
AF:
0.585
AC:
111104
AN:
189948
AF XY:
0.606
show subpopulations
Gnomad AFR exome
AF:
0.193
Gnomad AMR exome
AF:
0.371
Gnomad ASJ exome
AF:
0.585
Gnomad EAS exome
AF:
0.434
Gnomad FIN exome
AF:
0.698
Gnomad NFE exome
AF:
0.690
Gnomad OTH exome
AF:
0.613
GnomAD4 exome
AF:
0.669
AC:
950460
AN:
1420538
Hom.:
325821
Cov.:
81
AF XY:
0.672
AC XY:
471759
AN XY:
702484
show subpopulations
African (AFR)
AF:
0.184
AC:
5958
AN:
32330
American (AMR)
AF:
0.383
AC:
15189
AN:
39682
Ashkenazi Jewish (ASJ)
AF:
0.588
AC:
14949
AN:
25436
East Asian (EAS)
AF:
0.455
AC:
16876
AN:
37106
South Asian (SAS)
AF:
0.666
AC:
54262
AN:
81476
European-Finnish (FIN)
AF:
0.697
AC:
34540
AN:
49528
Middle Eastern (MID)
AF:
0.623
AC:
3561
AN:
5716
European-Non Finnish (NFE)
AF:
0.704
AC:
768199
AN:
1090436
Other (OTH)
AF:
0.628
AC:
36926
AN:
58828
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
20041
40082
60123
80164
100205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19334
38668
58002
77336
96670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.527
AC:
80270
AN:
152176
Hom.:
24673
Cov.:
33
AF XY:
0.529
AC XY:
39368
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.210
AC:
8718
AN:
41530
American (AMR)
AF:
0.462
AC:
7067
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.599
AC:
2081
AN:
3472
East Asian (EAS)
AF:
0.461
AC:
2385
AN:
5178
South Asian (SAS)
AF:
0.647
AC:
3126
AN:
4832
European-Finnish (FIN)
AF:
0.707
AC:
7485
AN:
10592
Middle Eastern (MID)
AF:
0.602
AC:
177
AN:
294
European-Non Finnish (NFE)
AF:
0.696
AC:
47332
AN:
67972
Other (OTH)
AF:
0.543
AC:
1146
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1675
3350
5025
6700
8375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.641
Hom.:
10545
Bravo
AF:
0.491
TwinsUK
AF:
0.708
AC:
2624
ESP6500AA
AF:
0.230
AC:
1008
ESP6500EA
AF:
0.699
AC:
5988
ExAC
AF:
0.542
AC:
63557
Asia WGS
AF:
0.540
AC:
1877
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 08, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:4
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Pontocerebellar hypoplasia type 4 Benign:2
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pontocerebellar hypoplasia type 2A Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pontoneocerebellar hypoplasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Pontocerebellar hypoplasia type 5 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.54
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
24
DANN
Benign
0.95
DEOGEN2
Benign
0.083
T
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.37
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.0000042
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
3.9
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-2.4
N
Sift
Benign
0.047
D
Sift4G
Uncertain
0.0060
D
Vest4
0.19
ClinPred
0.032
T
GERP RS
4.5
Varity_R
0.32
gMVP
0.44
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9911502; hg19: chr17-73518203; COSMIC: COSV51342116; COSMIC: COSV51342116; API